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CORONARY HEART DISEASE PREDICTION AND PREVENTION
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Introduction
Prediction of coronary heart disease (CHD) is based on
multivariable risk equations developed from population-based
observational studies in which people without clinical CHD at
the initiation of study were examined and followed until their
first CHD events. The risk equations from the Framingham Heart
Study have been widely used in our clinical practice1-3 and
research.4,5 The recent report of the third National Cholesterol
Education Program-Adult Treatment Panel (NCEP-ATP)
incorporated the Framingham risk equations to predict ten-year
absolute CHD risk and to identify certain patients who are at
high risk and more likely to benefit from primary prevention with
aggressive lipid-lowering treatment.1 In addition to CHD
prediction, population-based observational studies also provide
the clue to understand how much of CHD can be prevented by
modifying major cardiovascular risk factors such as serum
cholesterol level, blood pressure level, and current smoking.4,6,7
In this narrative review, we described how CHD prediction works
and how it can be improved by including nontraditional cardiovascular risk factors. We also discussed about how likely it is to
prevent the majority of CHD.

How Do We Predict CHD?
The Framingham Heart Study has developed mathematical
functions to assess the relative importance of CHD risk factors
and to quantify absolute CHD risk for individual patients.8-10
Detailed methods of derivation of CHD risk equations were
described elsewhere.8 Briefly, sex-specific CHD risk equations

were derived from a population-based sample of 2489 men and
2856 women, 30 to 74 years of age, who were free of overt cardiovascular disease at the time of their 11th examination of the
original Framingham Cohort or the initial examination of the
Framingham Offspring Study in 1971 to 1974. CHD risk factors
were routinely and systematically measured during these
examinations and twelve-year follow-up was obtained for the
development of “hard” CHD events, defined as myocardial
infarction and CHD death. Sex-specific Cox proportional hazards
regression was performed to calculate the relative importance of
CHD risk factors using age, current smoking, presence of
diabetes, the fifth Joint National Committee on Hypertension
blood pressure categories, and the second NCEP-ATP cholesterol
categories as covariates. (Table 1) In addition, score sheets were
developed from the beta-coefficients of Cox proportional hazards
models to provide ten-year absolute CHD risk and to make it
easy to implement as part of a screening program. They were
adopted by the NCEP-ATP III guideline.1 (Figure 1) The
predictive capability of the model using a continuous variable or
a categorical variable for cholesterol level was almost identical.8
The equation is particularly useful when there are multiple mild
abnormalities that increase CHD risk synergistically.
In the Framingham risk equation, several candidate risk factors
such as family history of CHD, elevated fibrinogen levels, left
ventricular hypertrophy on the electrocardiogram, postmenopausal
estrogen replacement therapy, physical activity, high serum
triglyceride, and body mass index, were not included for practical
reasons, although they may contribute to the risk of CHD.8

Table 1. Multivariate-Adjusted Relative Risks (RR) for CHD from the Framingham
Heart Study: Twelve-Year Follow-Up of 2489 Men and 2856 Women
(Adapted from Wilson et al8)
Risk Factors
Age (Years)
Blood Pressure
Normal
High Normal
Hypertension Stage I
Hypertension Stage II
Cigarette Use (Yes/No)
Diabetes (Yes/No)
LDL Cholesterol (mg/dL)
<130
130-159
>160
HDL Cholesterol (mg/dL)
<35
35-59
>60

Men
RR
1.05‡

95% CI
1.04-1.06

Women
RR
1.04‡

95% CI
1.03-1.06

1.00
1.32
1.73‡
1.92‡
1.71‡
1.47*

Referent
0.98-1.78
1.32-2.26
1.42-2.59
1.39-2.10
1.04-2.08

1.00
1.34
1.75†
2.19‡
1.49†
1.80†

Referent
0.88-2.05
1.21-2.54
1.46-3.27
1.13-1.97
1.18-2.74

1.00
1.19
1.74‡

Referent
0.91-1.54
1.36-2.24

1.00
1.24
1.68†

Referent
0.84-1.81
1.17-2.40

1.46†
1.00
0.61*

1.15-1.85
Referent
0.41-0.91

2.08†
1.00
0.64†

1.33-3.25
Referent
0.47-0.87

* 0.01 < P < 0.05, † 0.001 < P < 0.01, ‡ P < 0.001.
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How Well Does CHD Prediction Equation Work?
The performance of the CHD risk prediction models has
been examined according to discrimination and
calibration.4,5 From the coefficients of the prediction
model, a risk score can be calculated for each person by
multiplying the person’s risk factor level by the associated
coefficient for that risk variable, then summing all these
products. Those with a higher risk score from a
prediction model are expected to have higher CHD
events. Discrimination is the ability of a predictive model
to separate those who experience hard CHD events from
those who do not. It can be quantified by c-statistic or
the area under a receiver operating characteristic (ROC)
curve (AUC) which indicates the probability that a
person who had an incident CHD event within a
specified time had a higher risk score than a person who
did not have an event by that time.11,12 The AUC has a
range between 0.5 and 1. When the variables in the
prediction model are unrelated to the event, the expected
AUC would be 0.5. The greater the AUC is, the better
the prediction model works. Calibration, another
measure of performance of the prediction model,
measures how closely predicted outcomes agree with
actual outcomes.
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Figure 1. Score Sheets for Estimation of Ten-Year CHD Risk for Men and Women (Adapted from NCEP-ATP III Guideline1)
Since the Framingham risk equation was derived from a
community sample of white middle-class individuals from a
suburb of Boston, concerns have existed regarding its generalizability to other populations.8 To test the validity, the sex-specific
Framingham risk equations were applied to six prospectively
studied, ethnically diverse cohorts including the Atherosclerosis
Risk in Communities Study (ARIC), Physicians’ Health Study,
Honolulu Heart Program, Puerto Rico Heart Health Program,
Strong Heart Study, and the Cardiovascular Health Study.5 The
performance of the predication equation was compared using
discrimination and calibration. For white men and women and for

black men and women, the Framingham risk equations performed
reasonably well within five years of follow-up. (Figure 2) Among
Japanese American and Hispanic men and Native American
women, the equation overestimated the risk. However, after taking
into account different prevalence of risk factors and underlying
CHD rates, it performed well in these populations.
Then, how much of incident CHD events are explained by known
risk factors? The CHD prediction equations have been used to
answer this question. In the Seven Countries Study, the prediction
equation using systolic blood pressure, cholesterol, smoking, and
age derived from the US railroad workers was applied to men in
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five European countries.13 Fifty one percent of CHD events
occurred in top quintile of the predicted CHD risk. Based on this
finding, it is often said that only 50 percent of the CHD is
explained by the known risk factors. In another study, the
Framingham equation was applied to the National Health and
Nutrition Examination Survey I, a probability sample of the US
population.14 Thirty nine percent of CHD deaths in men and 59
percent in women occurred in top quintile of the predicted risk.
Based on these findings, can we say that approximately 40 to 60
percent of CHD mortality is due to known causes and the
remaining percent is due to unknown causes? This is a very
common misinterpretation. Counting cases attributable to the
upper end of the risk distribution defined by an arbitrarily high
cut point on the scale is misleading, because most of the risk
factors have a continuous graded relationship to risk.15
In a study using five large cohorts of young and middle-aged adults
in the Multiple Risk Factor Intervention Trial (MRFIT) and Chicago
Heart Association Detection Project in Industry (CHA) who were
free of diabetes and myocardial infarction, low-risk participants who
had cholesterol level less than 200 mg/dL, blood pressure less than
or equal to 120/80 mmHg, and no current smoking, experienced
significantly and markedly lower CHD death rates by 77 to 92
percent than the rest of the cohorts during the mean follow-up
period of 16 years for MRFIT and 22 years for CHA.6 This suggests
that three major risk factors – serum cholesterol level, blood pressure,
and smoking – account for the majority of CHD death. Similar
results were found in the ARIC study.4 Not being in the bottom
decile of risk score derived from traditional risk factors accounted
for 72-75 percent of CHD risk in men and 89-93 percent in women.
Evidences from numerous cohort studies with long follow-up have
shown that the major established risk factors explain at least 75% of
the CHD events within populations and there is no evidence
supporting the only-50-percent claim.

Can We Improve CHD Risk Equation?
If traditional risk factors in the Framingham risk equation – total
cholesterol, HDL cholesterol, current smoking, diabetes, and
blood pressure – can explain 75 percent of incident CHD events,

how can the remaining 25 percent be explained? Investigators in
the ARIC study examined the improvement in the predictive
capability of the basic risk equation by adding the following
nontraditional risk factors: body mass index, waist-hip ratio, Keys
score, albumin, white blood cell count, “residual” forced expiratory
volume at 1 second (FEV1) (calculated as the difference between
measured FEV1 and the predicted FEV1 from age, height, and
sex), fibrinogen, factor VII, von Willebrand Factor, lipoprotein(a),
heart rate, pack years cigarette smoking, sport activity index, and
creatinine.4 Among the nontraditional risk factors considered, no
single factor provided a large improvement in predictive capability
of the basic equations only including total cholesterol, HDL
cholesterol, systolic blood pressure, antihypertensive medications,
current smoking, and diabetes. When nontraditional risk factors
and intima-media thickness were added to the basic model, the
predictive capacity of the model was significantly improved, as
measured by the gain in the AUC above the 0.5. (Table 2)

Have We Reached the Limits in CHD Prediction?
In the ARIC study, 531 CHD events occurred among 4287 white
men during ten years of follow-up period since the baseline
examination in 1987.4 If we were able to predict CHD perfectly,
we could identify those 531 high-risk men at baseline: 100 percent
of them should develop CHD events within ten years and none
of the remaining 3756 low-risk men would have events. This is
theoretically impossible because the CHD risk exists in
continuum in a population. Some practical limitations also exist.
The CHD events can be unrecognized because of silent
myocardial infarction, microinfarction, or unwitnessed deaths.
Oftentimes deaths are falsely attributed to CHD. In addition,
true CHD risk may relate more closely to lifetime cholesterol level
or blood pressure level rather than their levels measured at one
point or during a relatively short period. Blood tests may not
precisely measure atherogenic or thrombogenic processes. There
is always a possibility of unmeasured or undiscovered risk factors
as well. Even if the science were complete, there still exists a source
of variation from random effects. For these reasons, we will never
be able to predict CHD perfectly.

Table 2. Area Under the ROC Curves Comparing Basic and Full Models
(Adapted and modified from Chambless at el4)*
Model
Basic†
Full‡

Black Women
N=1798; n=90
0.830
0.845

White Women
N=5006; n=198
0.793
0.805

Black Men
N=1102; n=101
0.669
0.720

White Men
N=4082; n=504
0.685
0.733

* N indicates sample size and n indicates the number of CHD events.
† Basic model included total cholesterol, HDL cholesterol, systolic blood pressure, antihypertensive medications, current smoking, and diabetes.
‡ Full model included body mass index, waist-hip ratio, Keys score, albumin, residual
FEV1, fibrinogen, factor VII, von Willebrand Factor, lipoprotein(a), heart rate, pack
years cigarette smoking, sport activity index, and intima-media thickness.
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If research since 1979 has improved overall
prediction so little, have we discovered all the
important risk factors? Is there any evidence that
we could predict CHD events better? Some
indirect historical evidences suggest that there is
more to be discovered. In William Osler’s lecture
to Royal College of Physicians in 1910,16 the
number of angina cases per hospital admissions
was approximately 1 case per year in large
hospitals. In his perspectives,17 Paul Dudley
White, a graduate of Harvard Medical School
in 1911 and founding member of the American
Heart Association and International Council of
Cardiology, described that there were very few
angina cases after review of his voluminous notes
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Figure 2. Five-Year Prediction for Hard CHD Events: Performance Measures for Atherosclerosis Risk in Communities Study Men and Women
(Adapted from D’Agostino et al5)
X-axes refer to decile of predicted risk based on the Framingham Heart Study function.
during his medical internship at the Massachusetts General
Hospital from 1912 to 1913. Among his 100 publications in his
early career between 1913 and 1926, there were only two papers
related to CHD. According to these evidences, CHD may have
been a rare disease in 1910. However, problems exist with historical
evidences: they were mainly personal observations and there are
major concerns about diagnostic accuracy such as the unavailability
of electrocardiogram or cardiac enzyme tests. It is also possible that
people did not live long enough to develop CHD.
Besides historical evidences, ecological evidences provide an
opportunity to examine the different characteristics and their
potential contribution to incident CHD events among populations
in different geographic locations. In the International
Atherosclerosis Project18 where 21302 autopsies from 15
geographic locations and four race-sex groups were assessed, the
age-adjusted percent of intimal surface of coronary arteries
involved with raised atherosclerotic lesions varied up to three folds
from 6 percent in Durban Bantu or Guatemala to 18 percent in
New Orleans whites and Oslo. Prevalence of coronary stenosis
among those aged 45 to 54 years also varied from 0 percent in
Durban Bantu to 20 percent in New Orleans whites. Another

autopsy study compared the prevalence of myocardial infarction
between African Americans and Africans in Nigeria and between
Asian Americans and Asians in Japan and Korea.19 The authors
concluded that very low prevalence of myocardial infarction in
Africa and Asia was due to environment, not genetics. In a study
comparing CHD incidence in men aged 45 to 64 years who
participated in three large National Heart Lung Blood Institutesupported cohort studies in the 1960s, the incidence of CHD in
Honolulu Japanese and Puerto Rico men was only 40 percent of
that observed in the Framingham Heart Study.20 It was suggested
that lower levels of risk factors during early lifetime might be
responsible for lower CHD incidence. In the Seven Countries
Study, ten-year CHD mortality in 16 cohorts was strongly
associated with median serum cholesterol levels and the incidence
of CHD mortality in low-rate cohorts was 11 percent of that in
high-rate cohorts.21 Similar findings between serum cholesterol
level and CHD mortality were observed in other studies.7,22
Estimated CHD reduction effect of lowering cholesterol by
0.6mmol (23.2 mg/dL) was 27 percent in cohort studies and 38%
percent in ecological studies.7 Like historical evidences, ecologic
evidences are not free from limitations: interpretation may be
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Figure 3. Incidence of CHD According to Diastolic Blood Pressure, Serum Cholesterol, and Body Mass Index (Adapted from Law et al25)
Data were obtained from cohort studies. Incidence was plotted on arithmetic scale (left hand plots) and logarithmic scale (right hand plots).
affected by possible genetic difference. In addition, secular changes
in many populations have diminished research opportunities.
Despite abovementioned limitations, both historical and ecological
evidences suggest that some human adult populations have
extremely low CHD event rates and provide a unique perspective
to better understand the incidence of CHD events.

Is It Possible to Prevent 90 Percent of CHD Events?
Historical and ecological comparisons have suggested the potential
for preventing a large proportion of CHD events in contemporary
western countries.7,18,20-24 It may be possible to prevent 90 percent of
CHD events by reducing standard risk factors to optimal levels. In
the MRFIT and CHA studies, young non-smoking men with
cholesterol level less than 200 mg/dL and blood pressure less than
or equal to 120/80 mmHg had 86 to 92 percent less CHD events
than the rest of male participants.6 Similar results were observed in
the ARIC study.4 The benefit from low risk profile was greater for
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individuals with persisting low risk profile. These studies are
prospectively conducted and their estimates are unbiased. Is it
feasible for high-risk individuals to reduce their risk to optimal
levels? A meta-analysis of risk factor associations with CHD showed
that a given change in a risk factor reduces the risk of CHD by a
constant proportion of the existing risk regardless of the starting
level of the existing risk.25 (Figure 3) The authors also emphasized
that individuals should be selected for preventive treatment only
based on a person’s absolute risk level and high-risk individuals
should receive interventions to modify all reversible risk factors
simultaneously.25 With good motivation from high-risk individuals
and aggressive strategies against multiple modifiable risk factors, we
may be able to achieve large risk reduction. Then, we can ask
whether entire populations can reduce their risk to optimal levels.
When the exposure to a risk factor is homogeneous within a
population, the case-control and cohort methods will fail to detect
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the risk factor as a cause of an outcome. As a result, the approach
aiming at high-risk individuals without a population approach will
only protect susceptible individuals, but will not control the causes
of incidence in the population.26 According to population-based
studies,4,6 more than 90 percent has higher than optimal risk levels.
People at less than highest risk are less motivated to change their
risk levels and interventions have lower benefit to risk ratios.
Therefore, a population strategy is essential for substantial effect.26
There is also evidence that today’s average levels of risk factors
should not be considered normal.25 When risk factor levels in our
ancestors were estimated through studies of isolated communities
with a hunter-gatherer lifestyle typical of the Stone Age, the rise in
risk factor levels that is currently seen in Western populations did
not occur in hunter-gatherer communities and the shift in the
Western distributions made current averages high in relation to the
prehistoric values. (Table 3) Moreover, lowering all risk factors to
optimal levels might not be necessary to prevent the majority of
CHD, because even low-risk populations did not have optimal
levels of all risk factors. In the Seven Countries Study, the
population in Crete had average blood pressure of 134/80 mmHg
and 57 percent of smokers and the population in Japan had average
blood pressure of 130/72 mmHg and 75% of smokers.21 It seems
that very low cholesterol level itself may suffice.
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Conclusions
Coronary heart disease is not an inevitable consequence of aging.
Major established risk factors can explain 75 to 90 percent of the
incidence of coronary heart disease within populations. If the
entire population could reduce known risk factor levels to 1st
decile, up to 90 percent prevention might be achieved.
If persistent low cholesterol levels can be achieved by population
strategies affecting childhood, it alone might achieve 90 percent
prevention when the children become adults.
Although nontraditional risk factors add little to overall risk
prediction, they might provide effective prevention opportunities.
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